#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Graft versus host disease Chronic lymphocytic leukaemia recurrent Hereditary neuropathic amyloidosis Lymphangioma Microvillous inclusion disease Osteomyelitis Synovial sarcoma recurrent Adrenoleukodystrophy Acute myeloid leukaemia recurrent Testicular leiomyosarcoma Fusarium infection Fibrosarcoma metastatic Indolent systemic mastocytosis Haematological malignancy More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Diagnostics Lymphangiosarcoma Sjogren’s syndrome – Life with Disease Osteosarcoma metastatic – Life with Disease Immunodeficiency congenital – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Basal cell naevus syndrome – Treatment Krabbe’s disease – Basic Information Krabbe’s disease – Diagnostics Testicular leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mecasermin Rinfabate Ecoo1A Lysine Acetate TX000045 Nafarelin Ursodoxicoltaurine Retinol Palmitate Testosterone Undecanoate Magrolimab TALADEGIB Crinecerfont Rbl007.2 Upadacitinib Absk021 Hydrochloride Hydrate Briquilimab GRAPHITE Vemircopan Poractant Alfa Irbesartan Gandotinib More therapies…

    Learn about Your Condition

    Electrocorticogram Osteogenesis imperfecta Peritoneal sarcoma Eyelid ptosis Biotinidase deficiency Thrombotic microangiopathy Breast cancer stage III Microvillous inclusion disease Barrett's oesophagus Malignant fibrous histiocytoma Tourette's disorder Retinitis pigmentosa Chondroplasty Axial spondyloarthritis Lung adenocarcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Nipocalimab
    Austria Bulgaria Czechia Denmark France Germany +9

  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Axatilimab
    Austria Belgium Czechia Finland France Germany +8

  • Study on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    • Elebsiran
    • Tobevibart
    Austria France Germany Italy Romania Spain

  • Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Remibrutinib
    • SALICYLIC ACID
    Bulgaria Denmark Germany Greece Italy Poland +3

  • Study on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Postural orthostatic tachycardia syndrome
    Investigated Drugs:
    • Human Plasma Protein
    • Human Normal Immunoglobulin
    Germany Italy Spain

  • Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • JNJ-75276617
    • Idarubicin Hydrochloride
    France Germany Italy Spain

  • Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vorasidenib
    • Temozolomide
    Austria France Germany Italy The Netherlands Spain

  • Study of Domvanalimab and Zimberelimab Combined with Chemotherapy for Previously Untreated Recurrent or Metastatic Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Carboplatin
    France Italy Spain

  • Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Bulgaria France Germany Hungary Italy Poland +1

  • Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Amg 193
    Belgium Czechia France Germany Greece Hungary +6
Previous Page
1 … 38 39 40 41 42 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!